Market revenue in 2022 | USD 311.1 million |
Market revenue in 2030 | USD 3,640.1 million |
Growth rate | 36% (CAGR from 2022 to 2030) |
Largest segment | Deep learning |
Fastest growing segment | Natural language processing |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.75% in 2022. Horizon Databook has segmented the Asia Pacific artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
Some Asian countries have also started their national genomics initiatives, establishing their population genetic databases by sequencing the DNA of healthy people. For instance, Thailand recently authorized the USD 150 million 5-year Genomics Thailand Initiative to characterize the genomes of 50,000 citizens.
Singapore has a national precision medicine strategy that includes genetic material of 10,000 ethnically diverse, healthy people of Singapore. The second phase of the strategy is to increase the data bank to 100,000 healthy persons and increase the application of precision medicine in clinical practice.
In June 2020, Infosys, a pioneer in next-generation digital services and consulting, announced the launch of personalized medicine solution for the pharmaceutical sector. With the solution, pharmaceutical companies would handle business and regulatory needs while providing patients.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific artificial intelligence in precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account